✦ LIBER ✦

Enzyme efflux in experimental myopathy

✍ Scribed by Tetsuo Furukawa; Hideo Sugita

Book ID: 115766039
Publisher: Elsevier Science
Year: 1971
Tongue: English
Weight: 225 KB
Volume: 5
Category: Article
ISSN: 0006-2944
DOI: 10.1016/0006-2944(71)90041-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beta adrenergic-mediated myofibrillar di

Beta adrenergic-mediated myofibrillar disruption and enzyme efflux in an experimental myopathy related to isometric muscle activity

✍ Ralph W. Kuncl; Herbert Y. Meltzer 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 834 KB

Myopathy in experimental uremia

✍ H. D. Bundschu; D. Pfeilsticker; C. Matthews; E. Ritz 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 759 KB

Experimental simvastatin-induced myopath

Experimental simvastatin-induced myopathy in rabbits

✍ Keiichi Nakahara; Masaru Kuriyama; Hiroaki Yoshidome; Kazuya Nagata; Tatsui Naga 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Increased axoplasmic flow in experimenta

Increased axoplasmic flow in experimental ischemic myopathy

✍ P.L. Wood; R.J. Boegman 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Distribution of muscle changes in experi

Distribution of muscle changes in experimental ischemic myopathy

✍ Dr. Toshiyuki Maki; Dr. Jan K. Korthals; Leon D. Prockop 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

The distribution of ischemic changes was examined in the medial gastrocnemius muscle of the cat, following transient simultaneous clamping of the aorta and femoral artery. Initial changes occurred in the middle portion of the muscle, in the areas corresponding to watershed zones of the primary arter

The role of proteases in experimental gl

The role of proteases in experimental glucocorticoid myopathy

✍ Abbot F. Clark; Dr. Paul J. Vignos Jr. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

## Abstract Mature, male, New Zealand white rabbits were treated with the synthetic glucocorticoid betamethasone (0.3 mg/kg body weight/day) for 2 weeks. The glucocorticoid treatment caused a 30% decrease in muscle weight of the type 2 psoas muscle, but had no apparent effect on the type 1 soleus m